Hypertriglyceridemia-induced acute pancreatitis

References

• Singla A, Csikesz NG, Simons JP et al. National hospital volume in acute pancreatitis: analysis of the Nationwide Inpatient Sample 1998–2006. HPB (Oxford) 11(5), 391–397 (2009).
   Google Scholar
• Whitcomb DC. Clinical practice. Acute pancreatitis. N. Engl. J. Med. 354(20), 2142–2150 (2006).
   Google Scholar
• Fortson MR, Freedman SN, Webster PD III. Clinical assessment of hyperlipidemic pancreatitis. Am. J. Gastroenterol. 90, 2134–2139 (1995).
   Google Scholar
• Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol. Clin. North Am. 19, 783–791 (1990).
   Google Scholar
• Anderson F, Thomson SR, Clarke DL, Buccimazza I. Dyslipidaemic pancreatitis clinical assessment and analysis of disease severity and outcomes. Pancreatology 9(3), 252–257 (2009). ▪ Well‑conducted study demonstrating that 10% of all pancreatitis cases of a regional South African hospital were due to hypertriglyceridemia‑induced pancreatitis (HTGP). Additionally, a trend towards a more severe disease in HTGP (concerning mortality and complications) is shown.
   Google Scholar
• Chang CC, Hsieh YY, Tsai HD et al. Acute pancreatitis in pregnancy. Zhonghua Yi Xue Za Zhi 61, 85–92 (1998).
   Google Scholar
• Dominguez-Munoz JE, Malfertheiner P, Ditschuneit HH et al. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int. J. Pancreatol. 10, 261–267 (1991).
   Google Scholar
• Dominguez-Munoz JE, Junemann F, Malfertheiner P. Hyperlipidemia in acute pancreatitis. Cause or epiphenomenon? Int. J. Pancreatol. 18(2), 101–106 (1995).
   Google Scholar
• Cameron JL, Capuzzi DM, Zuidema GD et al. Acute pancreatitis with hyperlipiemia: the incidence of lipid abnormalities in acute pancreatitis. Ann. Surg. 177, 493–499 (1973).
   Google Scholar
• Sekimoto M, Takada T, Kawarada Y et al. JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J. Hepatobiliary Pancreat. Surg. 13(1), 10–24 (2006).
   Google Scholar
• Pitchumoni CS, Yegneswaran B. Acute pancreatitis in pregnancy. World J. Gastroenterol. 15, 5641–5646 (2009).
   Google Scholar
• Nitsche C, Maertin S, Scheiber J, Ritter CA, Lerch MM, Mayerle J. Drug-induced pancreatitis. Curr. Gastroenterol. Rep. 14, 131–138 (2012).
   Google Scholar
• Havel RJ. Pathogenesis, differentiation and management of hypertriglyceridemia. Adv. Intern. Med. 15, 117–145 (1969).
   Google Scholar
• Saharia P, Margolis S, Zuidema MD et al. Acute pancreatitis with hyperlipidemia: studies with an isolated perfused canine pancreas. Surgery 82, 60–67 (1977).
   Google Scholar
• Kimura W, Mossner J. Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int. J. Pancreatol. 20, 177–184 (1996).
   Google Scholar
• Pitchumoni CS, Agarwal N, Jain NK. Systemic complications of acute pancreatitis. Am. J. Gastroenterol. 83, 597–606 (1988).
   Google Scholar
• Cuthbertson CM, Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br. J. Surg. 93, 518–530 (2006).
   Google Scholar
• Zeng Y, Wang X, Zhang W, Wu K, Ma J. Hypertriglyceridemia aggravates ER stress and pathogenesis of acute pancreatitis. Hepatogastroenterology 59(119), 2318–2326 (2012).
   Google Scholar
• Chang YT, Chang MC, Su TC et al. Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis. Clin. Chem. 54, 131–138 (2008).
   Google Scholar
• Ivanova R, Puerta S, Garrido A et al. Triglyceride levels and apolipoprotein E polymorphism in patients with acute pancreatitis. Hepatobiliary Pancreat. Dis. Int. 11(1), 96–101 (2012).
   Google Scholar
• Baranyai T, Terzin V, Vajda A, Wittmann T, Czako L. Hypertriglyceridemia causes more severe course of acute pancreatitis. Clin. Lipidol. 7(6), 731–736 (2012). ▪▪ Hungarian study of 351 patients with pancreatitis that suggests a more severe prognosis, more frequent pancreatic necrosis, sepsis and local complications, and longer hospitalization in patients with HTGP.
   Google Scholar
• Hofbauer B, Friess H, Weber A et al. Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the rat. Gut 38, 753–758 (1996).
   Google Scholar
• Czako L, Szabolcs A, Vajda A et al. Hyperlipidemia induced by a cholesterol-rich diet aggravates necrotizing pancreatitis in rats. Eur. J. Pharmacol. 572, 74–81 (2007).
   Google Scholar
• Wang YJ, Sun JB, Li F, Zhang SW. Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats. World J. Gastroenterol. 12, 2908–2913 (2006).
   Google Scholar
• Warshaw AL, Lesser PB, Rie M et al. The pathogenesis of pulmonary edema in acute pancreatitis. Ann. Surg. 182, 505–510 (1975).
   Google Scholar
• Kimura T, Toung JK, Margolis S et al. Respiratory failure in acute pancreatitis. A possible role for triglycerides. Ann. Surg. 189, 509–514 (1979).
   Google Scholar
• Lloret Linares C, Pelletier AL, Czernichow S et al. Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas 37(1), 13–22 (2008). ▪ Describes a rather large population of patients with severe HTGP. The prevalence and characteristics of HTGP complications are discussed and a clear trend towards a more severe disease in HTGP is demonstrated.
   Google Scholar
• Deng LH, Xue P, Xia Q et al. Effect of admission hypertriglyceridemia on the episodes of severe acute pancreatitis. World J. Gastroenterol. 14, 4558–4561 (2008).
   Google Scholar
• Balachandra S, Virlos IT, King NK et al. Hyperlipidaemia and outcome in acute pancreatitis. Int. J. Clin. Pract. 60(2), 156–159 (2006).
   Google Scholar
• Guzman S, Nervi F, Llanos O et al. Impaired lipid clearance in patients with previous acute pancreatitis. Gut 26, 888–889 (1985).
   Google Scholar
• Durrington PN, Twentyman OP, Braganza JM et al. HTG and laboratory abnormalities of triglyceride catabolism persisting after pancreatitis. Int. J. Pancreatol. 1, 195–203 (1986).
   Google Scholar
• Haber PS, Wilson JS, Apte MV et al. Lipid intolerance does not account for susceptibility to alcohol and gallstone pancreatitis. Gastroenterology 106, 742–748 (1994).
   Google Scholar
• Lindkvist B, Appelros S, Regnér S, Manjer J. A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose. Pancreatology 12(4), 317–324 (2012).
   Google Scholar
• Ewald N, Hardt PD, Kloer HU. Severe hypertriglyceridemia and pancreatitis: presentation and management. Curr. Opin. Lipidol. 20(6), 497–504 (2009).
   Google Scholar
• Jabbar MA, Zuhri-Yag MI, Larrea J. Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia. J. Am. Coll. Nutr. 17, 458–461 (1998).
   Google Scholar
• Mikhail N, Trivedi K, Page C et al. Treatment of severe hypertriglyceridemia in nondiabetic patients with insulin. Am. J. Emerg. Med. 23, 415–417 (2005).
   Google Scholar
• Tamez-Perez HE, Saenz-Gallegos R, Hernandez-Rodriguez K et al. Insulin therapy in patients with severe hypertriglyceridemia. Rev. Med. Inst. Mex. Seguro Soc. 44, 235–237 (2006).
   Google Scholar
• Brown RA, Leung E, Kankaanranta H, Moilanen E, Page CP. Effects of heparin and related drugs on neutrophil function. Pulm. Pharmacol. Ther. 25, 185–192 (2012).
   Google Scholar
• Sleth JC, Lafforgue E, Servais R et al. A case of hypertriglycideremia-induced pancreatitis in pregnancy: value of heparin. Ann. Fr. Anesth. Reanim. 23, 835–837 (2004).
   Google Scholar
• Twilla JD, Mancell J. Hypertriglyceridemia-induced acute pancreatitis treated with insulin and heparin. Am. J. Health Syst. Pharm. 69(3), 213–216 (2012).
   Google Scholar
• Alagozlu H, Mehmet C, Karakan T et al. Heparin and insulin in the treatment of hypertriglyceridemia-induced severe acute pancreatitis. Dig. Dis. Sci. 51, 931–933 (2006).
   Google Scholar
• Jain P, Rai RR, Udawat H et al. Insulin and heparin in treatment of hypertriglyceridemia-induced pancreatitis. World J. Gastroenterol. 13, 2642–2643 (2007).
   Google Scholar
• Weintraub M, Rassin T, Eisenberg S et al. Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation. J. Lipid Res. 35, 29–38 (1994).
   Google Scholar
• Nasstrom B, Olivecrona G, Olivecrona T et al. Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted. J. Lab. Clin. Med. 138, 206–213 (2001).
   Google Scholar
• Nasstrom B, Stegmayr B, Gupta J et al. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing. Nephrol. Dial. Transplant. 20, 1172–1179 (2005).
   Google Scholar
• Ewald N, Kloer HU. Severe hypertriglyceridemia: an indication for apheresis? Atheroscler. Suppl. 10(5), 49–52 (2009).
   Google Scholar
• Lennertz A, Parhofer KG, Samtleben W, Bosch T. Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis. Ther. Apher. 3(3), 227–233 (1999).
   Google Scholar
• Yeh JH, Lee MF, Chiu HC. Plasmapheresis for severe lipemia: comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants. J. Clin. Apher. 18(1), 32–36 (2003).
   Google Scholar
• Yeh JH, Chen JH, Chiu HC. Plasmapheresis for hyperlipidemic pancreatitis. J. Clin. Apher. 18(4), 181–185 (2003).
   Google Scholar
• Chen JH, Yeh JH, Lai HW, Liao CS. Therapeutic plasma exchange in patients with hyperlipidemic pancreatitis. World J. Gastroenterol. 10(15), 2272–2274 (2004).
   Google Scholar
• Stefanutti C, Di Giacomo S, Vivenzio A et al. Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study. Artif. Organs 33(12), 1096–1102 (2009).
   Google Scholar
• Kyriakidis AV, Karydakis P, Neofytou N et al. Plasmapheresis in the management of acute severe hyperlipidemic pancreatitis: report of 5 cases. Pancreatology 5, 201–204 (2005).
   Google Scholar
• Gubensek J, Buturovic-Ponikvar J, Marn-Pernat A et al. Treatment of hyperlipidemic acute pancreatitis with plasma exchange: a single-center experience. Ther. Apher. Dial. 13(4), 314–317 (2009).
   Google Scholar
• Kyriakidis AV, Raitsiou B, Sakagianni A et al. Management of acute severe hyperlipidemic pancreatitis. Digestion 73, 259–264 (2006).
   Google Scholar
• Kadikoylu G, Yavasoglu I, Bolaman Z. Plasma exchange in severe hypertriglyceridemia a clinical study. Transfus. Apher. Sci. 34, 253–257 (2006).
   Google Scholar
• Iskandar SB, Olive KE. Plasmapheresis as an adjuvant therapy for hypertriglyceridemia-induced pancreatitis. Am. J. Med. Sci. 328, 290–294 (2004).
   Google Scholar
• Furuya T, Komatsu M, Takahashi K et al. Plasma exchange for hypertriglyceridemic acute necrotizing pancreatitis: report of two cases. Ther. Apher. 6, 454–458 (2002).
   Google Scholar
• Ohmoto K, Neishi Y, Miyake I, Yamamoto S. Severe acute pancreatitis associated with hyperlipidemia: report of two cases and review of the literature in Japan. Hepatogastroenterology 46(29), 2986–2990 (1999).
   Google Scholar
• Stefanutti C, Di Giacomo S, Labbadia G. Timing clinical events in the treatment of pancreatitis and hypertriglyceridemia with therapeutic plasmapheresis. Transfus. Apher. Sci. 45(1), 3–7 (2011).
   Google Scholar
• Maki KC, Bays HE, Dicklin MR. Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence. J. Clin. Lipidol. 6(5), 413–426 (2012). ▪ Good review of the currently available treatment strategies for hypertriglyceridemia.
   Google Scholar
• Staels B, Dallongeville J, Auwerx J et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 2088–2093 (1998).
   Google Scholar
• Bays HE, Tighe AP, Sadovsky R, Davidson MH. Prescription w-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev. Cardiovasc. Ther. 6(3), 391–409 (2008).
   Google Scholar
• MacKay D, Hathcock J, Guarneri E. Niacin: chemical forms, bioavailability, and health effects. Nutr Rev. 70(6), 357–366 (2012).
   Google Scholar
• Mizushima T, Ochi K, Matsumura N et al. Prevention of hyperlipidemic acute pancreatitis during pregnancy with medium-chain triglyceride nutritional support. Int. J. Pancreatol. 23, 187–192 (1998).
   Google Scholar
• Hauenschild A, Bretzel RG, Schnell-Kretschmer H, Kloer HU, Hardt PD, Ewald N. Successful treatment of severe hypertriglyceridemia with a formula diet rich in w-3 fatty acids and medium-chain triglycerides. Ann. Nutr. Metab. 56(3), 170–175 (2010).
   Google Scholar
• Athyros VG, Giouleme OI, Nikolaidis NL et al. Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis. J. Clin. Gastroenterol. 34, 472–475 (2002).
   Google Scholar
• Piolot A, Nadler F, Cavallero E, Coquard JL, Jacotot B. Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas 13, 96–99 (1996).
   Google Scholar
• Hauenschild A, Ewald N, Schnell-Kretschmer H et al. Successful long-term treatment of severe hypertriglyceridemia by feedback control with lipid selfmonitoring. Ann. Nutr. Metab. 52, 215–220 (2008). ▪ Study of 32 patients with severe hypertriglyceridemia that proves the value of lipid self‑monitoring in the long‑term management of severe hypertriglyceridemia.
   Google Scholar
• Tsuang W, Navaneethan U, Ruiz L et al. Hypertriglyceridemic pancreatitis: presentation and management. Am. J. Gastroenterol. 104, 984–991 (2009). ▪▪ Valuable review that proposes a treatment algorithm for HTGP.
   Google Scholar
• Kylänpää L, Rakonczay Z Jr, O’Reilly DA. The clinical course of acute pancreatitis and the inflammatory mediators that drive it. Int. J. Inflam. 2012, 360685 (2012).
   Google Scholar
• Malmstrøm ML, Hansen MB, Andersen AM et al. Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis. Pancreas 41, 241–247 (2012).
   Google Scholar
• Gaudet D, Méthot J, Kastelein J. Gene therapy for lipoprotein lipase deficiency. Curr. Opin. Lipidol. 23(4), 310–320 (2012).
   Google Scholar